Cilostazol for Intermittent Claudication

A review of the Cochrane Vascular Specialized Register, CENTRAL, MEDLINE, Embase, CINAHL, and AMED databases, World Health Organization International Clinical Trials Registry Platform ClinicalTrials.gov trials registries on November 9, 2020. Participants taking cilostazol had higher initial claudication distance absolute compared with those placebo, along a possible improvement quality life (16 double-blind, randomized controlled trials). There was no difference detected between pentoxifylline for improving or (5 The most commonly reported adverse events were headache, gastrointestinal symptoms, palpitations. Cilostazol has been shown to improve walking in people intermittent claudication, but there distance. odds experiencing headache.